Guest guest Posted January 31, 2008 Report Share Posted January 31, 2008 Doctor Accused of Leak to Drug Maker The New York Times By STEPHANIE SAUL Published: January 31, 2008 A leading member of the Senate said Wednesday that a prominent diabetes expert had leaked an unpublished and confidential medical journal article to GlaxoKline last year, tipping the company to the imminent publication of safety questions involving the company's diabetes drug Avandia. The expert, Dr. M. Haffner of the University of Texas Health Science Center in San , faxed the article to the drug maker after agreeing to read it as part of the peer-review process for The New England Journal of Medicine, according to a statement Wednesday by Senator E. Grassley, Republican of Iowa. " The most troubling aspect of this situation is that the integrity of another aspect of the scientific process is called into question — scientific peer review, " Mr. Grassley's statement said. The peer-review process, he said, is meant to ensure " that other scientists will judge a study's quality before it is made public. " Mr. Grassley, the ranking Republican on the Finance Committee and a longtime critic of business dealings between doctors and drug companies, also released a copy of a letter he sent to GlaxoKline in which he asked what action the company took after receiving the letter. ***************************************************** Read the rest of the article here: http://www.nytimes.com/2008/01/31/business/31censure.html?ref=business -- Not an MD Quote Link to comment Share on other sites More sharing options...
Recommended Posts
Join the conversation
You are posting as a guest. If you have an account, sign in now to post with your account.
Note: Your post will require moderator approval before it will be visible.